Zoxid-O Oral Suspension
By Zoxid-O
Rx
200ml Oral Suspension in a Bottle

Composition
Sucralfate(1000mg) + Oxetacaine(20mg)

Manufacturer - Servocare Lifesciences Pvt Ltd
Servocare Lifesciences Private Limited, Chandigarh, Rahul Marwaha(Manager), SCF No. 246, Motor Market, Manimajra, Chandigarh - 160101, India

Expires on or after
July, 2025

liver
Safety Advice - Liver Limited information is available regarding the safety of Zoxid-O Oral Suspension in individuals with liver disease. It is highly recommended to consult with your doctor before using this medication if you have any preexisting liver conditions. Your healthcare provider will be able to assess the potential risks and benefits of using Doucid-S in relation to your liver health, and provide you with personalized guidance on the appropriate dosage and frequency of administration. It is crucial to prioritize your liver health and seek professional medical advice to ensure the safe and effective use of Zoxid-O Oral Suspension.

kidney
Use Zoxid-O Oral Suspension carefully if you have kidney disease. Your doctor may need to adjust the dosage. Consult with your doctor for proper guidance before using Zoxid-O Oral Suspension.

alcohol
It is advised to be cautious when drinking alcohol while taking Zoxid-O Oral Suspension. Consult your doctor for guidance.

driving
When using Zoxid-O Oral Suspension, be cautious as it may cause drowsiness, blurred vision, or dizziness. Avoid driving if experiencing these side effects.

pregnancy
Safety Advice for Pregnancy It is important to note that there is no specific information available about the use of Zoxid-O Oral Suspension during pregnancy. Therefore, it is recommended to consult your doctor before using this medication.

breastfeeding
It is better to consult your doctor before using Zoxid-O Oral Suspension during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | - |
₹145
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024